MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease
Background & Aims Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of...
Saved in:
Published in | Liver international Vol. 39; no. 8; pp. 1504 - 1513 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background & Aims
Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.
Methods
We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR‐30b or inhibit miR‐30b rats were injected with lentivirus particles containing PGLV3‐miR‐30b or PGLV3‐miR‐30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.
Results
Our data showed that miR‐30b was markedly up‐regulated in the liver of HFD–treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+‐ATPase 2b (SERCA2b), as a novel target of miR‐30b. Overexpression of miR‐30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR‐30b by miR‐30b antimiR suppressed ER stress and insulin resistance in HFD–treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR‐30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA‐IR) in human subjects.
Conclusions
Our findings suggest that miR‐30b represents not only a potential target for the treatment of insulin resistance, but also a non‐invasive disease biomarker of NAFLD. |
---|---|
AbstractList | Insulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.
We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR-30b or inhibit miR-30b rats were injected with lentivirus particles containing PGLV3-miR-30b or PGLV3-miR-30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.
Our data showed that miR-30b was markedly up-regulated in the liver of HFD-treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca
-ATPase 2b (SERCA2b), as a novel target of miR-30b. Overexpression of miR-30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR-30b by miR-30b antimiR suppressed ER stress and insulin resistance in HFD-treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR-30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA-IR) in human subjects.
Our findings suggest that miR-30b represents not only a potential target for the treatment of insulin resistance, but also a non-invasive disease biomarker of NAFLD. Background & AimsInsulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.MethodsWe used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR‐30b or inhibit miR‐30b rats were injected with lentivirus particles containing PGLV3‐miR‐30b or PGLV3‐miR‐30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.ResultsOur data showed that miR‐30b was markedly up‐regulated in the liver of HFD–treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+‐ATPase 2b (SERCA2b), as a novel target of miR‐30b. Overexpression of miR‐30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR‐30b by miR‐30b antimiR suppressed ER stress and insulin resistance in HFD–treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR‐30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA‐IR) in human subjects.ConclusionsOur findings suggest that miR‐30b represents not only a potential target for the treatment of insulin resistance, but also a non‐invasive disease biomarker of NAFLD. Insulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.BACKGROUND & AIMSInsulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR-30b or inhibit miR-30b rats were injected with lentivirus particles containing PGLV3-miR-30b or PGLV3-miR-30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.METHODSWe used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR-30b or inhibit miR-30b rats were injected with lentivirus particles containing PGLV3-miR-30b or PGLV3-miR-30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.Our data showed that miR-30b was markedly up-regulated in the liver of HFD-treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+ -ATPase 2b (SERCA2b), as a novel target of miR-30b. Overexpression of miR-30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR-30b by miR-30b antimiR suppressed ER stress and insulin resistance in HFD-treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR-30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA-IR) in human subjects.RESULTSOur data showed that miR-30b was markedly up-regulated in the liver of HFD-treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+ -ATPase 2b (SERCA2b), as a novel target of miR-30b. Overexpression of miR-30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR-30b by miR-30b antimiR suppressed ER stress and insulin resistance in HFD-treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR-30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA-IR) in human subjects.Our findings suggest that miR-30b represents not only a potential target for the treatment of insulin resistance, but also a non-invasive disease biomarker of NAFLD.CONCLUSIONSOur findings suggest that miR-30b represents not only a potential target for the treatment of insulin resistance, but also a non-invasive disease biomarker of NAFLD. Background & Aims Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity. Methods We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR‐30b or inhibit miR‐30b rats were injected with lentivirus particles containing PGLV3‐miR‐30b or PGLV3‐miR‐30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects. Results Our data showed that miR‐30b was markedly up‐regulated in the liver of HFD–treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+‐ATPase 2b (SERCA2b), as a novel target of miR‐30b. Overexpression of miR‐30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR‐30b by miR‐30b antimiR suppressed ER stress and insulin resistance in HFD–treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR‐30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA‐IR) in human subjects. Conclusions Our findings suggest that miR‐30b represents not only a potential target for the treatment of insulin resistance, but also a non‐invasive disease biomarker of NAFLD. |
Author | Li, Shu‐De Tang, Jun‐Rui Miao, Ying‐Lei Lv, Jun‐Yan Li, Chun‐Mei Zhang, Yuan‐Qing Chu, Yi‐You Zou, Cheng‐Gang Ma, Lan‐Qing Ma, Yan‐Qiong Ma, Yi‐Cheng Wang, Kun‐Hua Dai, Li‐Li |
Author_xml | – sequence: 1 givenname: Li‐Li surname: Dai fullname: Dai, Li‐Li organization: Yunnan University – sequence: 2 givenname: Shu‐De surname: Li fullname: Li, Shu‐De organization: Kunming Medical University – sequence: 3 givenname: Yi‐Cheng surname: Ma fullname: Ma, Yi‐Cheng organization: Yunnan University – sequence: 4 givenname: Jun‐Rui surname: Tang fullname: Tang, Jun‐Rui organization: Kunming Medical University – sequence: 5 givenname: Jun‐Yan surname: Lv fullname: Lv, Jun‐Yan organization: Kunming Medical University – sequence: 6 givenname: Yuan‐Qing surname: Zhang fullname: Zhang, Yuan‐Qing organization: Kunming Medical University – sequence: 7 givenname: Ying‐Lei surname: Miao fullname: Miao, Ying‐Lei organization: Kunming Medical University – sequence: 8 givenname: Yan‐Qiong surname: Ma fullname: Ma, Yan‐Qiong organization: Kunming Medical University – sequence: 9 givenname: Chun‐Mei surname: Li fullname: Li, Chun‐Mei organization: Kunming Medical University – sequence: 10 givenname: Yi‐You surname: Chu fullname: Chu, Yi‐You organization: Kunming Medical University – sequence: 11 givenname: Kun‐Hua surname: Wang fullname: Wang, Kun‐Hua email: kunhuawang1@163.com organization: Kunming Medical University – sequence: 12 givenname: Lan‐Qing surname: Ma fullname: Ma, Lan‐Qing email: 531229897@qq.com organization: Kunming Medical University – sequence: 13 givenname: Cheng‐Gang orcidid: 0000-0001-5519-4402 surname: Zou fullname: Zou, Cheng‐Gang email: chgzou@ynu.edu.cn organization: Yunnan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30721562$$D View this record in MEDLINE/PubMed |
BookMark | eNp90b1uHCEQB3AU2Yo_kiIvECGlcYqzGWBhtzydnMTS2ZGcjxYBy56xONYB1tF1eYQ8Y57E2Oe4sJTQDMXvPxrNHKCdOEaH0Bsgx1DfSfC3x8CJkC_QPnDZzhhlsPP0p2wPHeR8TQh0XQMv0R4jkkIj6D66Ovc2jZcX8z-_fjNicHKrKejiMvYxT8FHnF3MvvhbXzbYbHDRaeWKjyv85fRyMaemQlznqXkd7Hg1Bm_xoEvVdSyXcO-z09m9QruDDtm9fqyH6NuH06-LT7Pl549ni_lyZlnD5EyblnOnRe-k4BQsBd6RphWtoMQKxvWgewbGGNkbrQlIDdoa4JaSphsGyw7R0bbvTRp_TC4XtfbZuhB0dOOUFYWOgyC0aSt994xej1OKdTpFqZBUSuCiqrePajJr16ub5Nc6bdTfHVbwfgvqInNObngiQNT9fVRdhHq4T7Unz6z1RRc_xpK0D_9L_PTBbf7dWi3Pvm8Td7Gdojg |
CitedBy_id | crossref_primary_10_1093_hmg_ddac088 crossref_primary_10_1016_j_biopha_2020_110655 crossref_primary_10_3390_ijms20122922 crossref_primary_10_1186_s12944_020_01261_3 crossref_primary_10_1096_fj_202401464R crossref_primary_10_1055_a_1587_9211 crossref_primary_10_1016_j_lfs_2020_119011 crossref_primary_10_1080_21655979_2022_2026858 crossref_primary_10_3390_ijms24119168 crossref_primary_10_1016_j_taap_2022_116161 crossref_primary_10_1016_j_biopha_2021_112462 crossref_primary_10_1080_10408398_2023_2202762 crossref_primary_10_3390_biomedicines13020370 crossref_primary_10_3390_ijms241914482 crossref_primary_10_1016_j_biopha_2020_109930 crossref_primary_10_1007_s00580_024_03620_3 crossref_primary_10_1016_j_ejbt_2024_10_004 crossref_primary_10_1080_14728222_2022_2170780 crossref_primary_10_1016_j_scitotenv_2021_145285 crossref_primary_10_3389_fphar_2021_770652 crossref_primary_10_1016_j_biopha_2020_110127 crossref_primary_10_3390_biomedicines11061597 crossref_primary_10_1016_j_aohep_2020_04_012 crossref_primary_10_3390_ijms20215266 crossref_primary_10_1038_s41598_024_57794_5 crossref_primary_10_1186_s13098_023_01137_3 crossref_primary_10_26599_FSHW_2024_9250096 crossref_primary_10_3389_fphar_2024_1477212 crossref_primary_10_1016_j_arr_2023_102123 crossref_primary_10_1371_journal_pone_0274794 crossref_primary_10_1016_j_phymed_2021_153845 crossref_primary_10_3389_fbioe_2022_858558 crossref_primary_10_1080_1828051X_2023_2222743 crossref_primary_10_1002_hep_31994 |
Cites_doi | 10.1126/science.1209038 10.1016/j.jhep.2016.12.016 10.3748/wjg.v20.i2.475 10.1111/j.1440-1746.2011.06864.x 10.1136/gutjnl-2014-308430 10.1210/en.2008-0794 10.1126/science.1103160 10.1074/jbc.M109.056648 10.1126/science.1158042 10.1016/j.cell.2009.01.002 10.1002/hep.27153 10.1038/sj.emboj.7600596 10.1186/1471-2164-11-249 10.1159/000366394 10.1016/j.cell.2010.02.034 10.1038/nature09968 10.1038/nature10112 10.1152/ajpgi.00426.2010 10.1016/j.mce.2015.02.018 10.1073/pnas.1012044107 10.1016/j.cell.2011.08.033 10.1126/science.1079817 10.1126/science.1128294 10.1053/j.gastro.2006.10.014 10.1074/jbc.M115.705012 10.1073/pnas.1118922109 10.5812/hepatmon.40263 10.1371/journal.pone.0047786 10.1016/j.cell.2012.02.017 10.3390/nu9040387 10.1053/j.gastro.2004.11.018 10.1002/hep.22569 10.2174/138161210791208875 10.1016/j.jhep.2012.08.008 10.1186/s12864-015-1896-3 10.1038/nrm2199 10.1016/j.dld.2010.01.016 |
ContentType | Journal Article |
Copyright | 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. 2019 John Wiley & Sons A/S |
Copyright_xml | – notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. – notice: 2019 John Wiley & Sons A/S |
DBID | AAYXX CITATION NPM 7QO 7T5 7U9 8FD FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1111/liv.14067 |
DatabaseName | CrossRef PubMed Biotechnology Research Abstracts Immunology Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Genetics Abstracts Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed Genetics Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1478-3231 |
EndPage | 1513 |
ExternalDocumentID | 30721562 10_1111_liv_14067 LIV14067 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Ministry of Education of the People’s Republic of China funderid: No. 213035A – fundername: National Natural Science Foundation of China funderid: No. 81560099; No.81360128 – fundername: Yunnan Provincial Science and Technology Department funderid: 2018FA039 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OC 29L 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY NPM 1OB 7QO 7T5 7U9 8FD FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3537-ab844ea6de76421c214905868620c634afad31bbb7dbaa017a1acb14c2059ffc3 |
IEDL.DBID | DR2 |
ISSN | 1478-3223 1478-3231 |
IngestDate | Fri Jul 11 09:15:18 EDT 2025 Wed Aug 13 07:41:25 EDT 2025 Mon Jul 21 06:06:43 EDT 2025 Tue Jul 01 04:10:04 EDT 2025 Thu Apr 24 23:02:38 EDT 2025 Wed Jan 22 16:39:49 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | microRNA NAFLD insulin resistance endoplasmic reticulum stress |
Language | English |
License | 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3537-ab844ea6de76421c214905868620c634afad31bbb7dbaa017a1acb14c2059ffc3 |
Notes | Funding information This work was supported, in part, by grants from the National Natural Science Foundation of China (No. 81560099 and No.81360128), a grant from the Ministry of Education of the People's Republic of China (No. 213035A), a key project from the Department of Science and Technology of Yunnan Province (2018FA039). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5519-4402 |
PMID | 30721562 |
PQID | 2267277146 |
PQPubID | 2045125 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2194160258 proquest_journals_2267277146 pubmed_primary_30721562 crossref_primary_10_1111_liv_14067 crossref_citationtrail_10_1111_liv_14067 wiley_primary_10_1111_liv_14067_LIV14067 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2019 |
PublicationDateYYYYMMDD | 2019-08-01 |
PublicationDate_xml | – month: 08 year: 2019 text: August 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Liver international |
PublicationTitleAlternate | Liver Int |
PublicationYear | 2019 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2010; 11 2011; 334 2010; 16 2015; 16 2010; 107 2017; 66 2010; 285 2009; 150 2010; 140 2006; 313 2012; 148 2004; 306 2008; 320 2016; 16 2014; 60 2017; 9 2009; 136 2011; 474 2011; 473 2005; 24 2014; 20 2011; 147 2011; 300 2010; 42 2013; 58 2011; 108 2007; 132 2005; 128 2016; 65 2007; 8 2008; 48 2015; 418 2012; 27 2016; 291 2012; 7 2003; 300 2014; 34 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
References_xml | – volume: 132 start-page: 282 issue: 1 year: 2007 end-page: 293 article-title: Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis publication-title: Gastroenterology – volume: 147 start-page: 81 issue: 1 year: 2011 end-page: 94 article-title: The Lin28/let‐7 axis regulates glucose metabolism publication-title: Cell – volume: 42 start-page: 320 issue: 5 year: 2010 end-page: 330 article-title: From the metabolic syndrome to NAFLD or vice versa? publication-title: Dig Liver Dis – volume: 300 start-page: G697 issue: 5 year: 2011 end-page: 702 article-title: Obesity, diabetes mellitus, and liver fibrosis publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 11 start-page: 249 year: 2010 article-title: Small RNA expression and strain specificity in the rat publication-title: BMC Genom – volume: 58 start-page: 119 issue: 1 year: 2013 end-page: 125 article-title: miR‐34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non‐alcoholic fatty liver disease publication-title: J Hepatol – volume: 291 start-page: 5185 issue: 10 year: 2016 end-page: 5198 article-title: Small molecular allosteric activator of the sarco/endoplasmic reticulum Ca2+‐ATPase (SERCA) attenuates diabetes and metabolic disorders publication-title: J Biol Chem – volume: 9 start-page: E387 issue: 4 year: 2017 article-title: Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments publication-title: Nutrients – volume: 418 start-page: 55 issue: Pt 1 year: 2015 end-page: 65 article-title: Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link? publication-title: Mol Cell Endocrinol – volume: 16 start-page: 699 year: 2015 article-title: Weight‐reduction through a low‐fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice publication-title: BMC Genom – volume: 24 start-page: 1243 issue: 6 year: 2005 end-page: 1255 article-title: TRB3, a novel ER stress‐inducible gene, is induced via ATF4‐CHOP pathway and is involved in cell death publication-title: EMBO J – volume: 136 start-page: 215 issue: 2 year: 2009 end-page: 233 article-title: MicroRNAs: target recognition and regulatory functions publication-title: Cell – volume: 66 start-page: 816 issue: 4 year: 2017 end-page: 824 article-title: MicroRNA‐206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis publication-title: J Hepatol – volume: 148 start-page: 852 issue: 5 year: 2012 end-page: 871 article-title: Mechanisms for insulin resistance: common threads and missing links publication-title: Cell – volume: 27 start-page: 331 issue: 2 year: 2012 end-page: 340 article-title: Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways publication-title: J Gastroenterol Hepatol – volume: 300 start-page: 1574 issue: 5625 year: 2003 end-page: 1577 article-title: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver publication-title: Science – volume: 473 start-page: 528 issue: 7348 year: 2011 end-page: 531 article-title: Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity publication-title: Nature – volume: 334 start-page: 1081 issue: 6059 year: 2011 end-page: 1086 article-title: The unfolded protein response: from stress pathway to homeostatic regulation publication-title: Science – volume: 150 start-page: 277 issue: 1 year: 2009 end-page: 285 article-title: The molecular mechanism of endoplasmic reticulum stress‐induced apoptosis in PC‐12 neuronal cells: the protective effect of insulin‐like growth factor I publication-title: Endocrinology – volume: 7 start-page: e47786 issue: 10 year: 2012 article-title: miRandola: extracellular circulating microRNAs database publication-title: PLoS ONE – volume: 65 start-page: 1850 issue: 11 year: 2016 end-page: 1860 article-title: MicroRNA‐21 is a potential link between non‐alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1‐p53‐Srebp1c pathway publication-title: Gut – volume: 8 start-page: 519 issue: 7 year: 2007 end-page: 529 article-title: Signal integration in the endoplasmic reticulum unfolded protein response publication-title: Nat Rev Mol Cell Biol – volume: 140 start-page: 900 issue: 6 year: 2010 end-page: 917 article-title: Endoplasmic reticulum stress and the inflammatory basis of metabolic disease publication-title: Cell – volume: 20 start-page: 475 issue: 2 year: 2014 end-page: 485 article-title: Limitations of liver biopsy and non‐invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis publication-title: World J Gastroenterol – volume: 313 start-page: 1137 issue: 5790 year: 2006 end-page: 1140 article-title: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes publication-title: Science – volume: 128 start-page: 343 issue: 2 year: 2005 end-page: 350 article-title: Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C publication-title: Gastroenterology – volume: 34 start-page: 1983 issue: 6 year: 2014 end-page: 1997 article-title: Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease publication-title: Cell Physiol Biochem – volume: 16 start-page: 1941 issue: 17 year: 2010 end-page: 1951 article-title: Insulin resistance in nonalcoholic fatty liver disease publication-title: Curr Pharm Des – volume: 48 start-page: 1810 issue: 6 year: 2008 end-page: 1820 article-title: Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression publication-title: Hepatology – volume: 108 start-page: 21075 issue: 52 year: 2011 end-page: 21080 article-title: Control of glucose homeostasis and insulin sensitivity by the Let‐7 family of microRNAs publication-title: Proc Natl Acad Sci USA – volume: 107 start-page: 19320 issue: 45 year: 2010 end-page: 19325 article-title: Sarco(endo)plasmic reticulum Ca2+‐ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity publication-title: Proc Natl Acad Sci USA – volume: 474 start-page: 649 issue: 7353 year: 2011 end-page: 653 article-title: MicroRNAs 103 and 107 regulate insulin sensitivity publication-title: Nature – volume: 320 start-page: 1492 issue: 5882 year: 2008 end-page: 1496 article-title: Regulation of hepatic lipogenesis by the transcription factor XBP1 publication-title: Science – volume: 306 start-page: 457 issue: 5695 year: 2004 end-page: 461 article-title: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes publication-title: Science – volume: 60 start-page: 554 issue: 2 year: 2014 end-page: 564 article-title: Inhibition of microRNA‐24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia publication-title: Hepatology – volume: 285 start-page: 6198 issue: 9 year: 2010 end-page: 6207 article-title: Hepatic Bax inhibitor‐1 inhibits IRE1alpha and protects from obesity‐associated insulin resistance and glucose intolerance publication-title: The Journal of biological chemistry – volume: 16 start-page: e40263 issue: 9 year: 2016 article-title: Noninvasive diagnosis of hepatic steatosis using fat attenuation parameter measured by FibroTouch and a new algorithm in CHB patients publication-title: Hepatitis monthly – ident: e_1_2_9_15_1 doi: 10.1126/science.1209038 – ident: e_1_2_9_14_1 doi: 10.1016/j.jhep.2016.12.016 – ident: e_1_2_9_37_1 doi: 10.3748/wjg.v20.i2.475 – ident: e_1_2_9_36_1 doi: 10.1111/j.1440-1746.2011.06864.x – ident: e_1_2_9_13_1 doi: 10.1136/gutjnl-2014-308430 – ident: e_1_2_9_31_1 doi: 10.1210/en.2008-0794 – ident: e_1_2_9_24_1 doi: 10.1126/science.1103160 – ident: e_1_2_9_18_1 doi: 10.1074/jbc.M109.056648 – ident: e_1_2_9_32_1 doi: 10.1126/science.1158042 – ident: e_1_2_9_8_1 doi: 10.1016/j.cell.2009.01.002 – ident: e_1_2_9_12_1 doi: 10.1002/hep.27153 – ident: e_1_2_9_30_1 doi: 10.1038/sj.emboj.7600596 – ident: e_1_2_9_33_1 doi: 10.1186/1471-2164-11-249 – ident: e_1_2_9_34_1 doi: 10.1159/000366394 – ident: e_1_2_9_19_1 doi: 10.1016/j.cell.2010.02.034 – ident: e_1_2_9_22_1 doi: 10.1038/nature09968 – ident: e_1_2_9_10_1 doi: 10.1038/nature10112 – ident: e_1_2_9_2_1 doi: 10.1152/ajpgi.00426.2010 – ident: e_1_2_9_7_1 doi: 10.1016/j.mce.2015.02.018 – ident: e_1_2_9_21_1 doi: 10.1073/pnas.1012044107 – ident: e_1_2_9_25_1 doi: 10.1016/j.cell.2011.08.033 – ident: e_1_2_9_29_1 doi: 10.1126/science.1079817 – ident: e_1_2_9_17_1 doi: 10.1126/science.1128294 – ident: e_1_2_9_4_1 doi: 10.1053/j.gastro.2006.10.014 – ident: e_1_2_9_23_1 doi: 10.1074/jbc.M115.705012 – ident: e_1_2_9_26_1 doi: 10.1073/pnas.1118922109 – ident: e_1_2_9_28_1 doi: 10.5812/hepatmon.40263 – ident: e_1_2_9_27_1 doi: 10.1371/journal.pone.0047786 – ident: e_1_2_9_20_1 doi: 10.1016/j.cell.2012.02.017 – ident: e_1_2_9_3_1 doi: 10.3390/nu9040387 – ident: e_1_2_9_38_1 doi: 10.1053/j.gastro.2004.11.018 – ident: e_1_2_9_9_1 doi: 10.1002/hep.22569 – ident: e_1_2_9_5_1 doi: 10.2174/138161210791208875 – ident: e_1_2_9_11_1 doi: 10.1016/j.jhep.2012.08.008 – ident: e_1_2_9_35_1 doi: 10.1186/s12864-015-1896-3 – ident: e_1_2_9_16_1 doi: 10.1038/nrm2199 – ident: e_1_2_9_6_1 doi: 10.1016/j.dld.2010.01.016 |
SSID | ssj0019951 |
Score | 2.4259655 |
Snippet | Background & Aims
Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased... Insulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum... Background & AimsInsulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1504 |
SubjectTerms | Adenosine triphosphatase Algorithms Biomarkers Ca2+-transporting ATPase Calcium Calcium ions Diet Disease resistance DNA microarrays Endoplasmic reticulum endoplasmic reticulum stress Fatty liver High fat diet Human subjects In vivo methods and tests Insulin Insulin resistance Liver Liver diseases microRNA MicroRNAs miRNA NAFLD Obesity Ribonucleic acid RNA Steatosis Stress Target recognition |
Title | MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fliv.14067 https://www.ncbi.nlm.nih.gov/pubmed/30721562 https://www.proquest.com/docview/2267277146 https://www.proquest.com/docview/2194160258 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BbtQwEB1VPSAuBVoKCwW5CCEuqZLYSRxxWlWtSsX2sFDUQ6VoxnFExZKi7i5SOfEJfGO_pGM7iShQCXGLlLHsxB7PG_vNDMDLNJEac5KRlRSzg2IxIp00ERmX_KzBgrQLcJ4c5QfH6vAkO1mBN30sTMgPMRy4Oc3w-7VTcKT5L0o-O_vGas6bLe-_jqvlANF0SB3lIo-9s6Xc9T_bwC6rkGPxDC1v2qI_AOZNvOoNzv49OO2HGngmn3eWC9ox33_L4vif33If1jogKsZh5TyAFduuw8a4ZSf8y6V4JTw11J-5r8OdSXcDvwGfJo7BNz0aX_34KWMSF6GWvZ2LjtUu5o4SH2pSCLoUgWrOBlK835vujlNiQdGet9weQ3neMyMaXLD0zHFERHdl9BCO9_c-7B5EXbWGyMhMFhGSVspiXtvCBc-alH2vONMuAiXmiVfYYC0TIipqQuSNABM0lCiTMsJrGiM3YZV7t49BZI1qyrwmyrNSWa1Rm0KVVhPquowxHcHrft4q06UydxU1ZlXv0vCAK_9DR_BiEP0a8nf8TWirn_yqU-F5xbiUsV3BlmQE28NrVj53o4KtPV-yTFIyoGXYqEfwKCyaoRfpMs8xuuTB-qm_vfvq3duP_uHJv4s-hbsM3cpARdyC1cXF0j5jeLSg514PrgHi2w1J |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbhNBEC2FIAEXloTFEKBBgLhMNPv0HDhYWeSQ2AeToNyGrp4eEsWMUTwGmROfwIfwK_wEX0JVzyLCInHJgZstl93tmaruV9OvXgE88b1AqhgDxwToUoJilIPSKxzULH5WqAQlFzgPR_HgIHx5GB0uwde2FqbWh-geuHFk2PWaA5wfSP8U5ZPjDxTntNo2lMpds_hICdvsxc4m3d2nvr-9tb8xcJqeAo4OoiBxFMowNCrOTcIlntqnDMGNJNdJuDS9UBUqDzxETHJUitxVeUqjF2qfcEhR6IB-9wJc5A7irNS_Oe7EqrjW2aZ3IRMOaNdtdIyYN9RN9ezu9xukPYuQ7Ra3fQ2-tRenZracrM8rXNefftGN_F-u3nW42mBt0a-D4wYsmXIFVvulqqbvFuKZsOxXe6ywApeGDclgFY6GTFIcj_rfP38JXBSn5i33ODMz0RD3xYxZ_3XbDYELUbPpCQOIV1vjjb6PZCjKaUnfV3UH4mMtClWR9YRpMKI5FbsJB-fy92_BMo1u7oCIirBI4xwxjtLQSKmkTsLUSFQyT13l9-B56yiZbtTauWnIJGuzNppwZm9gDx53pu9riZI_Ga213pY1q9QsI-hN8DWhzbIHj7qPaX3hQyNVmumcbLyUMDshY9mD27WXdqMELK5HAJoma33t78Nnezuv7Yu7_276EC4P9od79H60ew-uEFJNa-blGixXp3Nzn9BghQ9sEAp4c95--wPjiGvH |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtQwEB6VIlVc-Gn5WShgECAuqZLYSZwDh1W3q5ayK7RQ1FvwOA5ULNmqmwUtJx6B9-BVeAqehHHiRJQfiUsP3BJlEjvOjP1N_M0MwIMw4FLFyD3D0ScHxSgPZVB4qG3ys0IlKG2A82gc7x6Ip4fR4Qp8bWNhmvwQ3Q83axn1fG0N_DgvfjLy6dEHMnOabB2jct8sP5K_Nn-yN6CP-zAMhzsvt3c9V1LA0zziiadQCmFUnJvERnjqkBwEP5I2TMKn3glVqJwHiJjkqBRpqwqUxkDokGBIUWhOzz0H50Xsp7ZOxGDS5aqyoc61dycs34AWXZfGyNKGuq6eXvx-Q7SnAXK9wg0vwbd2bBpiy7utRYVb-tMvaSP_k8G7DBcd0mb9xjSuwIop12GjX6pq9n7JHrGa-1pvKqzD2shRDDbg7chSFCfj_vfPX7iP7MS8sRXOzJw52j6bW85_U3SD4ZI1XHpCAOzFzmS7HyIJsnJW0v2qqT98pFmhKpKeWhIMc3tiV-HgTF7_GqxS6-YGsKgQRRrniHGUCiOlkjoRqZGoZJ76KuzB41ZPMu1ytduSIdOs9dmow1n9AXtwvxM9bhKU_Elos1W2zM1R84yAN4HXhJbKHtzrLtPsYreMVGlmC5IJUkLshItlD643Stq1wm1qPYLP1Nla1f7efPZs71V9cPPfRe_C2vPBkE7H-7fgAsHUtKFdbsJqdbIwtwkKVninNkEGr89abX8AJuxqdg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA%E2%80%9030b+regulates+insulin+sensitivity+by+targeting+SERCA2b+in+non%E2%80%90alcoholic+fatty+liver+disease&rft.jtitle=Liver+international&rft.au=Dai%2C+Li%E2%80%90Li&rft.au=Li%2C+Shu%E2%80%90De&rft.au=Ma%2C+Yi%E2%80%90Cheng&rft.au=Tang%2C+Jun%E2%80%90Rui&rft.date=2019-08-01&rft.issn=1478-3223&rft.eissn=1478-3231&rft.volume=39&rft.issue=8&rft.spage=1504&rft.epage=1513&rft_id=info:doi/10.1111%2Fliv.14067&rft.externalDBID=10.1111%252Fliv.14067&rft.externalDocID=LIV14067 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-3223&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-3223&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-3223&client=summon |